US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Synaptogenix Inc (SNPX)
Synaptogenix Inc (SNPX) ニュース

SNPX

Synaptogenix (SNPX)

Synaptogenix Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SNPX

1 2 3 4 5 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/11/13	07 : 00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SNPX	Synaptogenix Inc
2024/11/07	22 : 54	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:SNPX	Synaptogenix Inc
2024/11/05	20 : 01	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:SNPX	Synaptogenix Inc
2024/10/29	05 : 00	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:SNPX	Synaptogenix Inc
2024/10/22	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:SNPX	Synaptogenix Inc
2024/10/11	06 : 11	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:SNPX	Synaptogenix Inc
2024/10/05	05 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SNPX	Synaptogenix Inc
2024/09/24	06 : 04	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:SNPX	Synaptogenix Inc
2024/09/14	05 : 54	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SNPX	Synaptogenix Inc
2024/09/11	22 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SNPX	Synaptogenix Inc
2024/09/11	22 : 00	PR Newswire (US)	Synaptogenix Announces $5.0 Million Financing	NASDAQ:SNPX	Synaptogenix Inc
2024/09/10	06 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SNPX	Synaptogenix Inc
2024/08/15	05 : 30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SNPX	Synaptogenix Inc
2024/07/18	22 : 00	PR Newswire (US)	Synaptogenix Announces New Collaboration with LSU Health New Orleans for Study of Proprietary Analogs in Spinal Cord Injury	NASDAQ:SNPX	Synaptogenix Inc
2024/06/26	22 : 00	PR Newswire (US)	Synaptogenix Announces FDA Authorization of IND Application for Clinical Trial for Bryostatin-1 in Multiple Sclerosis	NASDAQ:SNPX	Synaptogenix Inc
2024/05/16	06 : 03	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SNPX	Synaptogenix Inc
2024/05/07	22 : 00	PR Newswire (US)	Synaptogenix Applauds DEA Proposal to Reclassify Cannabis and Shares Expected Benefits to Cannasoul for Cannabinoid-Based Drug Discovery	NASDAQ:SNPX	Synaptogenix Inc
2024/04/24	22 : 15	PR Newswire (US)	Synaptogenix Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing	NASDAQ:SNPX	Synaptogenix Inc
2024/04/09	22 : 15	PR Newswire (US)	Synaptogenix Increases Stake in Innovative Psilocybin Drug Discovery Company through its Partnership with Cannasoul Analytics	NASDAQ:SNPX	Synaptogenix Inc
2024/04/03	21 : 00	PR Newswire (US)	Synaptogenix Announces Reverse Stock Split to Maintain Nasdaq Listing	NASDAQ:SNPX	Synaptogenix Inc
2024/02/07	00 : 16	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:SNPX	Synaptogenix Inc
2023/12/22	07 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SNPX	Synaptogenix Inc
2023/12/19	23 : 00	PR Newswire (US)	Synaptogenix President Daniel L. Alkon, M.D. Honored for Scientific Presentation at USC-Sponsored Forum on Age-Related Diseases and Neurodegenerative Disorders	NASDAQ:SNPX	Synaptogenix Inc
2023/12/06	23 : 00	PR Newswire (US)	Synaptogenix Joins Leading Neuroscientists and Academics as Speaker at USC-Sponsored Forum on Age-Related Diseases including Alzheimer's	NASDAQ:SNPX	Synaptogenix Inc
2023/11/15	07 : 05	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:SNPX	Synaptogenix Inc
2023/11/14	07 : 00	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:SNPX	Synaptogenix Inc
2023/11/07	07 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SNPX	Synaptogenix Inc
2023/11/04	06 : 00	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:SNPX	Synaptogenix Inc
2023/11/02	22 : 00	PR Newswire (US)	Synaptogenix Acquires Significant Stake in Cannasoul Analtyics Ltd. Co-founded by The Technion - Israel Institute of Technology	NASDAQ:SNPX	Synaptogenix Inc
2023/09/26	22 : 00	PR Newswire (US)	Synaptogenix Announces Peer-Reviewed Publication of NIH-Sponsored Phase 2 Clinical Trial Results Demonstrating Safe, Significant, and Persistent Benefits of Bryostatin-1 in Advanced Alzheimer's Disease	NASDAQ:SNPX	Synaptogenix Inc

Showing the most relevant articles for your search:NASDAQ:SNPX

1 2 3 4 5 次へ >>

American Express

Bank of America

US Dollar vs Euro

US Dollar vs Sterling

Financial Select Sector

Energy Select Sector SPDR

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約